Cipla Limited Investor Relations Material

Cipla Limited develops, manufactures, and markets pharmaceuticals products in India, the United States, South Africa, and internationally. It offers active pharmaceutical ingredients (APIs) and intermediates that comprise anesthetics/sedatives; analytical reference standards; antiretrovirals/antiretroviral intermediates; anticancer/oncology related APIs and intermediates; cardiovascular; dermatological, hair fall control drugs; diabetology; erectile dysfunction drugs; gastroenterology; malaria treatment drugs; musculoskeletal disorders related APIs and intermediates; nephrology-urology-anti-urolithiatic products; nepirology-urology-anti-urolithiatic products; nutritional supplements/vitamins/minerals/trace elements and herbal extracts for human health care products, as well as APIs for cosmetics industries. The company was incorporated in 1935 and is headquartered in Mumbai, India